[go: up one dir, main page]

WO2007136664A3 - Formulation antibiotique et procédé de traitement - Google Patents

Formulation antibiotique et procédé de traitement Download PDF

Info

Publication number
WO2007136664A3
WO2007136664A3 PCT/US2007/011754 US2007011754W WO2007136664A3 WO 2007136664 A3 WO2007136664 A3 WO 2007136664A3 US 2007011754 W US2007011754 W US 2007011754W WO 2007136664 A3 WO2007136664 A3 WO 2007136664A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug
formulation
treatment
particles
therapeutically effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/011754
Other languages
English (en)
Other versions
WO2007136664A2 (fr
Inventor
Reid Rubsamen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flow Focusing Inc
Original Assignee
Flow Focusing Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/383,562 external-priority patent/US20060263401A1/en
Application filed by Flow Focusing Inc filed Critical Flow Focusing Inc
Publication of WO2007136664A2 publication Critical patent/WO2007136664A2/fr
Publication of WO2007136664A3 publication Critical patent/WO2007136664A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La présente invention concerne une formulation contenant des particules qui peuvent être groupées et sont constituées d'un polymère biocompatible et d'un médicament antimicrobien, la formulation étant destinée à la libération contrôlée du médicament. Les particules peuvent se trouver dans une solution aqueuse comportant de la thrombine et être dispersées dans un gel. La formulation est appliquée sur une région telle qu'une plaie ouverte renfermant un implant orthopédique et elle libère une quantité thérapeutiquement efficace de médicament chez le patient durant un laps de temps thérapeutiquement efficace.
PCT/US2007/011754 2006-05-16 2007-05-16 Formulation antibiotique et procédé de traitement Ceased WO2007136664A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11/383,562 2006-05-16
US11/383,562 US20060263401A1 (en) 2001-07-13 2006-05-16 Formulation and Method for Preventing Infection
US80526706P 2006-06-20 2006-06-20
US60/805,267 2006-06-20
US82166806P 2006-08-07 2006-08-07
US60/821,668 2006-08-07

Publications (2)

Publication Number Publication Date
WO2007136664A2 WO2007136664A2 (fr) 2007-11-29
WO2007136664A3 true WO2007136664A3 (fr) 2008-05-02

Family

ID=38723813

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2007/011753 Ceased WO2007136663A2 (fr) 2006-05-16 2007-05-16 Formulation de protéine morphogène osseuse/antibiotique et procédé de traitement
PCT/US2007/011754 Ceased WO2007136664A2 (fr) 2006-05-16 2007-05-16 Formulation antibiotique et procédé de traitement

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2007/011753 Ceased WO2007136663A2 (fr) 2006-05-16 2007-05-16 Formulation de protéine morphogène osseuse/antibiotique et procédé de traitement

Country Status (1)

Country Link
WO (2) WO2007136663A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113710294A (zh) * 2019-04-18 2021-11-26 德普伊新特斯产品公司 用于药物递送贮库的手术中制备的生物相容性有机凝胶基质

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US6228398B1 (en) * 1998-11-02 2001-05-08 Elan Corporation, Plc Multiparticulate modified release composition
US20020165608A1 (en) * 2001-05-07 2002-11-07 Llanos Gerard H. Local drug delivery devices and methods for maintaining the drug coatings thereon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US5939323A (en) * 1996-05-28 1999-08-17 Brown University Hyaluronan based biodegradable scaffolds for tissue repair
US6743446B2 (en) * 1999-12-15 2004-06-01 The Ohio State University Research Foundation Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US6228398B1 (en) * 1998-11-02 2001-05-08 Elan Corporation, Plc Multiparticulate modified release composition
US20020165608A1 (en) * 2001-05-07 2002-11-07 Llanos Gerard H. Local drug delivery devices and methods for maintaining the drug coatings thereon

Also Published As

Publication number Publication date
WO2007136663A3 (fr) 2008-11-06
WO2007136664A2 (fr) 2007-11-29
WO2007136663A2 (fr) 2007-11-29

Similar Documents

Publication Publication Date Title
WO2010039641A3 (fr) Dispositifs d’administration à long terme de médicament à polymères à base de polyuréthanne et leur fabrication
WO2011026614A3 (fr) Compositions et procédés destinés à désinfecter des matériaux
WO2007133520A3 (fr) Revêtement de dispositifs médicaux comprenant un oxyde minéral ou céramique et un agent thérapeutique
WO2007089544A3 (fr) Implants non ophtalmiques biodégradables et méthodes en rapport
WO2005034852A3 (fr) Biomateriaux et biocoacervats proteiniques, leurs procedes de fabrication et d'utilisation
Gimeno et al. Porous orthopedic steel implant as an antibiotic eluting device: prevention of post-surgical infection on an ovine model
EP3373989B1 (fr) Films désintégrables biocompatibles secs pour poser une membrane de coquille d' oeuf particulaire sur une plaie
WO2008014191A3 (fr) Appareil et procédé pour manipuler ou rétracter des tissus et des structures anatomiques
Tsourvakas Local antibiotic therapy in the treatment of bone and soft tissue infections
WO2005070008A3 (fr) Revetement en nanofibres de promedicament donneur de non polymerique pour des dispositifs medicaux et therapie associee
BRPI0513243A (pt) composições oftálmicas e métodos para tratar condições oftálmicas
WO2010141133A3 (fr) Systèmes de fibroïne de soie pour apport antibiotique
WO2008002586A3 (fr) Enrobages destinés à des dispositifs médicaux, comprenant un agent thérapeutique et une matière métallique
WO2007139760A3 (fr) Compositions polymériques résorbables à usage médical, dentaire et chirurgical
WO2008039923A3 (fr) Chausson antimicrobien en deux parties
WO2002022182A1 (fr) Preparation pour pansements
WO2006073786A3 (fr) Compositions opthalmiques comprenant un steroide et une cyclosporine pour le traitement de l'oeil sec
AU2013298102B2 (en) Compositions and methods for the treatment of bone voids and open fractures
WO2006044890A3 (fr) Squelettes autofixants
UA105502C2 (uk) Імплантований пристрій для введення октреатиду та спосіб його використання
WO2007136664A3 (fr) Formulation antibiotique et procédé de traitement
US9480828B2 (en) Treatment method for the inferior turbinate
Suba et al. Chitosan-based biomaterial in wound healing: a review
US20230414491A1 (en) Kits, systems, and methods for reducing surgical site infections
Kong et al. Current Advances of Antibacterial Biomaterials for Bone Regeneration

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07777099

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07777099

Country of ref document: EP

Kind code of ref document: A2